{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:39:14Z","timestamp":1792643954155,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["2031693"],"award-info":[{"award-number":["2031693"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["21FC1018"],"award-info":[{"award-number":["21FC1018"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20FC1045"],"award-info":[{"award-number":["20FC1045"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23FC1048"],"award-info":[{"award-number":["23FC1048"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Membranoproliferative glomerulonephritis (MPGN) is a rare glomerular injury that causes nephrotic syndrome and end-stage kidney disease. The nationwide demographics and treatment of Japanese patients with primary MPGN have not yet been reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collected clinical personal records of patients with primary MPGN between 2015 and 2018 from the national registry organized by the Japanese Ministry of Health, Labour, and Welfare and investigated the characteristics of primary MPGN throughout Japan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 258 patients with primary MPGN, 199 and 59 showed nephrotic and non-nephrotic syndrome, respectively. The median age at onset was higher in patients with nephrotic syndrome than in those with non-nephrotic syndrome (45 [24\u201363] vs. 35 [14\u201353] years, respectively; P\u2009=\u20090.010). The use of oral prednisolone was significantly higher in patients with nephrotic syndrome than in those with non-nephrotic syndrome (73.9% vs. 59.3%, respectively; P\u2009=\u20090.032). When patients were divided into three age groups: adolescent and young adult group (\u2264\u200939\u00a0years; n\u2009=\u200980), middle adult group (40\u201364\u00a0years; n\u2009=\u2009111), and older adult group (\u2265\u200965\u00a0years; n\u2009=\u200967), the use of oral prednisolone, cyclosporine, and mizoribine was significantly higher in the adolescent and young adult group than in the middle adult group. The mean dosage of oral prednisolone and mizoribine showed no differences among the three age groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The national registry of clinical personal records of primary MPGN could provide an informative insight into the characteristics, clinical features, and treatment approaches for patients with primary MPGN in Japan.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10157-023-02387-1","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T06:02:12Z","timestamp":1690610532000},"page":"928-935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal records"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-3667","authenticated-orcid":false,"given":"Naoki","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Sakate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"key":"2387_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMra1108178","volume":"366","author":"S Sethi","year":"2012","unstructured":"Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis\u2013a new look at an old entity. N Engl J Med. 2012;366:1119\u201331.","journal-title":"N Engl J Med"},{"key":"2387_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work G","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work G. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100:S1\u2013276.","journal-title":"Kidney Int"},{"key":"2387_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/ndt\/gfq665","volume":"26","author":"A McGrogan","year":"2011","unstructured":"McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant. 2011;26:414\u201330.","journal-title":"Nephrol Dial Transplant"},{"key":"2387_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10157-011-0430-4","volume":"15","author":"H Sugiyama","year":"2011","unstructured":"Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, et al. Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol. 2011;15:493\u2013503.","journal-title":"Clin Exp Nephrol"},{"key":"2387_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10157-012-0746-8","volume":"17","author":"H Sugiyama","year":"2013","unstructured":"Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, et al. Japan Renal Biopsy Registry and Japan Kidney Disease Registry: committee report for 2009 and 2010. Clin Exp Nephrol. 2013;17:155\u201373.","journal-title":"Clin Exp Nephrol"},{"key":"2387_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10157-020-01864-1","volume":"24","author":"R Yamamoto","year":"2020","unstructured":"Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, et al. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2020;24:526\u201340.","journal-title":"Clin Exp Nephrol"},{"key":"2387_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/BF02254182","volume":"9","author":"K Iitaka","year":"1995","unstructured":"Iitaka K, Ishidate T, Hojo M, Kuwao S, Kasai N, Sakai T. Idiopathic membranoproliferative glomerulonephritis in Japanese children. Pediatr Nephrol. 1995;9:272\u20137.","journal-title":"Pediatr Nephrol"},{"key":"2387_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s10157-012-0690-7","volume":"17","author":"T Kawamura","year":"2013","unstructured":"Kawamura T, Usui J, Kaseda K, Takada K, Ebihara I, Ishizu T, et al. Primary membranoproliferative glomerulonephritis on the decline: decreased rate from the 1970s to the 2000s in Japan. Clin Exp Nephrol. 2013;17:248\u201354.","journal-title":"Clin Exp Nephrol"},{"key":"2387_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/nep.12382","volume":"20","author":"Y Okuda","year":"2015","unstructured":"Okuda Y, Ishikura K, Hamada R, Harada R, Sakai T, Hamasaki Y, et al. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children. Nephrology (Carlton). 2015;20:286\u201392.","journal-title":"Nephrology (Carlton)"},{"key":"2387_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00467-015-3307-z","volume":"31","author":"Y Kawasaki","year":"2016","unstructured":"Kawasaki Y, Kanno S, Ono A, Suzuki Y, Ohara S, Sato M, et al. Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative glomerulonephritis. Pediatr Nephrol. 2016;31:1091\u20139.","journal-title":"Pediatr Nephrol"},{"key":"2387_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10157-017-1513-7","volume":"22","author":"N Nakagawa","year":"2018","unstructured":"Nakagawa N, Hasebe N, Hattori M, Nagata M, Yokoyama H, Sato H, et al. Clinical features and pathogenesis of membranoproliferative glomerulonephritis: a nationwide analysis of the Japan renal biopsy registry from 2007 to 2015. Clin Exp Nephrol. 2018;22:797\u2013807.","journal-title":"Clin Exp Nephrol"},{"key":"2387_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257397","volume":"16","author":"N Nakagawa","year":"2021","unstructured":"Nakagawa N, Mizuno M, Kato S, Maruyama S, Sato H, Nakaya I, et al. Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: a retrospective analysis of data from the Japan Renal Biopsy Registry. PLoS ONE. 2021;16: e0257397.","journal-title":"PLoS ONE"},{"key":"2387_CR13","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.1038\/s41598-020-64123-z","volume":"10","author":"N Nakagawa","year":"2020","unstructured":"Nakagawa N, Sofue T, Kanda E, Nagasu H, Matsushita K, Nangaku M, et al. J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan. Sci Rep. 2020;10:7351.","journal-title":"Sci Rep"},{"key":"2387_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236132","volume":"15","author":"T Sofue","year":"2020","unstructured":"Sofue T, Nakagawa N, Kanda E, Nagasu H, Matsushita K, Nangaku M, et al. Prevalence of anemia in patients with chronic kidney disease in Japan: a nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB). PLoS ONE. 2020;15: e0236132.","journal-title":"PLoS ONE"},{"key":"2387_CR15","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.2337\/dc21-1081","volume":"44","author":"H Nagasu","year":"2021","unstructured":"Nagasu H, Yano Y, Kanegae H, Heerspink HJL, Nangaku M, Hirakawa Y, et al. Kidney outcomes associated with SGLT2 inhibitors versus other glucose-lowering drugs in real-world clinical practice: the japan chronic kidney disease database. Diabetes Care. 2021;44:2542\u201351.","journal-title":"Diabetes Care"},{"key":"2387_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1253\/circrep.CR-21-0001","volume":"3","author":"N Enzan","year":"2021","unstructured":"Enzan N, Matsushima S, Ide T, Kaku H, Tohyama T, Funakoshi K, et al. Clinical characteristics and contemporary management of patients with cardiomyopathies in Japan\u2014Report from a national registry of clinical personal records. Circ Rep. 2021;3:142\u201352.","journal-title":"Circ Rep"},{"key":"2387_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.resinv.2022.03.003","volume":"60","author":"M Hayashida","year":"2022","unstructured":"Hayashida M, Kinjo T, Wada Y, Kitaguchi Y, Hanaoka M. Hierarchical cluster analysis based on disease-associated manifestations of patients with lymphangioleiomyomatosis: an analysis of the national database of designated intractable diseases of Japan. Respir Investig. 2022;60:570\u20137.","journal-title":"Respir Investig"},{"key":"2387_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10157-023-02337-x","volume":"27","author":"T Kimura","year":"2023","unstructured":"Kimura T, Ikeuchi H, Yoshino M, Sakate R, Maruyama S, Narita I, et al. Profiling of kidney involvement in systemic lupus erythematosus by deep learning using the National Database of Designated Incurable Diseases of Japan. Clin Exp Nephrol. 2023;27:519\u201327.","journal-title":"Clin Exp Nephrol"},{"key":"2387_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s10157-021-02098-5","volume":"25","author":"T Wada","year":"2021","unstructured":"Wada T, Ishimoto T, Nakaya I, Kawaguchi T, Sofue T, Shimizu S, et al. A digest of the evidence-based clinical practice guideline for nephrotic syndrome 2020. Clin Exp Nephrol. 2021;25:1277\u201385.","journal-title":"Clin Exp Nephrol"},{"key":"2387_CR20","first-page":"671","volume":"26","author":"H Sakaguchi","year":"1984","unstructured":"Sakaguchi H, Hazikano H, Hasegawa O, Ito H. Histological subtype of mesangiocapillary glomerulonephritis (MPGN type 1). Nihon Jinzo Gakkai Shi. 1984;26:671\u201389.","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"2387_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10157-015-1216-x","volume":"20","author":"S Nishi","year":"2016","unstructured":"Nishi S, Ubara Y, Utsunomiya Y, Okada K, Obata Y, Kai H, et al. Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin Exp Nephrol. 2016;20:342\u201370.","journal-title":"Clin Exp Nephrol"},{"key":"2387_CR22","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0272-6386(00)70258-7","volume":"35","author":"GL Braden","year":"2000","unstructured":"Braden GL, Mulhern JG, O\u2019Shea MH, Nash SV, Ucci AA Jr, Germain MJ. Changing incidence of glomerular diseases in adults. Am J Kidney Dis. 2000;35:878\u201383.","journal-title":"Am J Kidney Dis"},{"key":"2387_CR23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/ndt\/gfn554","volume":"24","author":"FD Zhou","year":"2009","unstructured":"Zhou FD, Zhao MH, Zou WZ, Liu G, Wang H. The changing spectrum of primary glomerular diseases within 15 years: a survey of 3331 patients in a single Chinese centre. Nephrol Dial Transplant. 2009;24:870\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"2387_CR24","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/ndt\/16.7.1364","volume":"16","author":"EM Briganti","year":"2001","unstructured":"Briganti EM, Dowling J, Finlay M, Hill PA, Jones CL, Kincaid-Smith PS, et al. The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant. 2001;16:1364\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"2387_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/ckj\/sfz073","volume":"13","author":"N Garam","year":"2020","unstructured":"Garam N, Prohaszka Z, Szilagyi A, Aigner C, Schmidt A, Gaggl M, et al. Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis. Clin Kidney J. 2020;13:225\u201334.","journal-title":"Clin Kidney J"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-023-02387-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T08:06:19Z","timestamp":1697529979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-023-02387-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1007\/s10157-023-02387-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,29]]},"assertion":[{"value":"19 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The original study protocol was approved by the ethics review board of the Japanese Society of Nephrology (approval number 70; December 10, 2019). The requirement for informed consent was waived because all data included in this dataset were de-identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}